MktsMarkets

Pacira BioSciences, Inc.
NASDAQ: PCRXKey statistics
PCRX News
Stories mentioning PCRX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 177,376 | 196,873 | 179,516 | 181,099 | 168,923 | 187,253 | 168,573 | 178,023 |
| Cost of Goods Sold | 36,413 | 40,299 | 34,278 | 40,866 | 34,306 | 39,886 | 38,864 | 44,262 |
| Gross Profit | 140,963 | 156,574 | 145,238 | 140,233 | 134,617 | 147,367 | 129,709 | 133,761 |
| Operating Expenses | ||||||||
| Research & Development | 28,072 | 37,804 | 25,966 | 28,200 | 25,342 | 23,897 | 19,104 | 20,338 |
| Sales General & Admin | 93,944 | 101,608 | 91,797 | 88,578 | 86,776 | 79,614 | 74,333 | 68,126 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 6,902 | 2,340 | 6,362 | 8,499 | 1,990 | 24,704 | (139,527) | 28,240 |
| Interest Income | 1,930 | 2,295 | 8,534 | 5,008 | 6,895 | 5,555 | 5,482 | 4,749 |
| Interest Expense | ||||||||
| Other Expense | (135.00) | (172.00) | (110.00) | (10,739) | 4,401 | (53.00) | (122.00) | (39.00) |
| Pretax Income | 4,998 | 571.00 | 9,524 | (1,927) | 8,706 | 25,526 | (138,856) | 36,584 |
| Tax Provision | 2,082 | (1,066) | 4,092 | 2,920 | 3,894 | 9,485 | 4,610 | 17,698 |
| Net Income (Loss) | 2,916 | 1,637 | 5,432 | (4,847) | 4,812 | 16,041 | (143,466) | 18,886 |
| Earnings Per Share (Basic) | 0.07 | 0.04 | 0.12 | (0.11) | 0.10 | 0.35 | (3.11) | 0.41 |
| Earnings Per Share (Diluted) | 0.07 | 0.04 | 0.12 | (0.11) | 0.10 | 0.35 | (3.11) | 0.39 |
| Weighted Average Shares Outstanding (Basic) | 40,461 | 44,566 | 44,038 | 45,459 | 46,275 | 46,245 | 46,134 | 46,174 |
| Weighted Average Shares Outstanding (Diluted) | 40,910 | 45,042 | 44,459 | 45,459 | 46,526 | 46,245 | 46,134 | 50,539 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PCRX
Pacira BioSciences, Inc. (NASDAQ: PCRX) is a stock listed on the Nasdaq Stock Market under the ticker symbol PCRX. It last traded at $36.43 (Nov 6, 2026, 4:00 PM ET), up 0.0% on the day. That gives Pacira BioSciences a market capitalisation of $1.5B and a price-to-earnings ratio of 99.8.
Over the past 52 weeks PCRX has traded between $18.80 and $36.66.
Revenue for the quarter ended Mar 31, 2026 was $177.4M; net income $2.9M. Revenue was up 5.0% from $168.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $177.4M | $2.9M | 1.6% |
| Dec 31, 2025 | $196.9M | $1.6M | 0.8% |
| Sep 30, 2025 | $179.5M | $5.4M | 3.0% |
| Jun 30, 2025 | $181.1M | -$4.8M | -2.7% |
From Pacira BioSciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…